UNICYCIVE THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Basic Shares Outstanding (Weighted Average) of 26.92 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- UNICYCIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 26.92M shares, a 118.80% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 23.91M shares, a 104.66% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 21.43M shares, a 102.72% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 18.07M shares, a 103.11% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 15.89M shares, a 137.17% increase from fiscal 2024.
- UNICYCIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 6.70M shares, a 72.70% decline from fiscal 2023.
- UNICYCIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 24.54M shares, a 62.98% increase from fiscal 2022.
- UNICYCIVE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 15.06M shares, a 28.96% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 26.92M shares 10-Q · filed 2026-08-12 | 25.42M shares 10-Q · filed 2026-08-12 | 24.09M shares derived: average of 3 quarters · filed 2026-08-12 | 22.58M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | 23.91M shares 10-Q · filed 2026-05-12 | 22.67M shares derived: average of 2 quarters · filed 2026-05-12 | 21.13M shares derived: average of 3 quarters · filed 2026-05-12 | 18.93M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | 21.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 19.75M shares derived: average of 2 quarters · filed 2026-03-30 | 17.27M shares derived: average of 3 quarters · filed 2026-08-12 | 15.89M shares 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | 18.07M shares 10-Q · filed 2025-11-12 | 15.18M shares derived: average of 2 quarters · filed 2026-08-12 | 14.04M shares 10-Q · filed 2025-11-12 | 13.16M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | 12.30M shares 10-Q · filed 2026-08-12 | 11.99M shares 10-Q · filed 2026-08-12 | 11.52M shares derived: average of 3 quarters · filed 2026-08-12 | 10.86M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | 11.68M shares 10-Q · filed 2026-05-12 | 116.82M shares 10-Q · filed 2025-05-14 | 11.13M shares derived: average of 2 quarters · filed 2026-05-12 | 10.38M shares derived: average of 3 quarters · filed 2026-05-12 | 8.73M shares derived: average of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | 10.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 9.73M shares derived: average of 2 quarters · filed 2026-03-30 | 7.75M shares derived: average of 3 quarters · filed 2026-03-30 | 6.70M shares 10-K · filed 2026-03-30 | 66.99M shares 10-K · filed 2025-03-31 | |||
| 2024-09-30 | 8.89M shares 10-Q · filed 2025-11-12 | 88.94M shares 10-Q · filed 2024-11-13 | 6.34M shares derived: average of 2 quarters · filed 2025-11-12 | 5.41M shares 10-Q · filed 2025-11-12 | 54.07M shares 10-Q · filed 2024-11-13 | 20.61M shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 3.79M shares 10-Q · filed 2025-08-14 | 37.91M shares 10-Q · filed 2024-08-14 | 3.64M shares 10-Q · filed 2025-08-14 | 36.40M shares 10-Q · filed 2024-08-14 | 24.52M shares derived: average of 3 quarters · filed 2025-08-14 | 26.55M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 34.91M shares 10-Q · filed 2025-05-14 | 34.88M shares derived: average of 2 quarters · filed 2025-05-14 | 34.13M shares derived: average of 3 quarters · filed 2025-05-14 | 29.41M shares derived: average of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | 34.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 33.74M shares derived: average of 2 quarters · filed 2025-03-31 | 27.57M shares derived: average of 3 quarters · filed 2025-03-31 | 24.54M shares 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | 32.63M shares 10-Q · filed 2024-11-13 | 23.93M shares derived: average of 2 quarters · filed 2024-11-13 | 21.10M shares 10-Q · filed 2024-11-13 | 19.54M shares derived: average of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | 15.23M shares 10-Q · filed 2024-08-14 | 15.23M shares 10-Q · filed 2024-08-14 | 15.18M shares derived: average of 3 quarters · filed 2024-08-14 | 15.15M shares derived: average of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | 15.23M shares 10-Q · filed 2024-05-13 | 15.15M shares derived: average of 2 quarters · filed 2024-05-13 | 15.12M shares derived: average of 3 quarters · filed 2024-05-13 | 15.10M shares derived: average of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | 15.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 15.07M shares derived: average of 2 quarters · filed 2024-03-28 | 15.06M shares derived: average of 3 quarters · filed 2024-03-28 | 15.06M shares 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | 15.06M shares 10-Q · filed 2023-11-14 | 15.05M shares derived: average of 2 quarters · filed 2023-11-14 | 15.05M shares 10-Q · filed 2023-11-14 | 15.05M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 15.03M shares 10-Q · filed 2023-08-14 | 15.02M shares 10-Q · filed 2023-08-14 | 15.04M shares derived: average of 3 quarters · filed 2023-08-14 | 14.82M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 15.00M shares 10-Q · filed 2023-05-16 | 15.05M shares derived: average of 2 quarters · filed 2023-05-16 | 14.75M shares derived: average of 3 quarters · filed 2023-05-16 | 13.26M shares derived: average of 4 quarters · filed 2023-05-16 | ||||
| 2021-12-31 | 15.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 14.63M shares derived: average of 2 quarters · filed 2023-03-31 | 12.68M shares derived: average of 3 quarters · filed 2023-03-31 | 11.68M shares 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | 14.17M shares 10-Q · filed 2022-11-14 | 11.47M shares derived: average of 2 quarters · filed 2022-11-14 | 10.54M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 8.77M shares 10-Q · filed 2022-08-15 | 8.68M shares 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | 8.58M shares 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | 8.50M shares 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |